Anti-ANGPTL4 nanobody [SAA1258] (STJN000300)

SKU:
STJN000300
£378.50 - £1,632.50
Free Shipping
Processing The item has been added

Host: Alpaca
Applications: ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description : Alpaca monoclonal nanobody anti-Angiopoietin-Related Protein 4 is suitable for use in ELISA research applications.
Clonality : Monoclonal
Clone ID : SAA1258
Conjugation: Unconjugated
Isotype: VHH-8His-Cys-tag
Formulation: 0.01M PBS, pH 7.4.
Purification: Purified by Nickel column.
Concentration: 1 mg/mL
Storage Instruction: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at-20°C 12 months. Store at-80°C long term.
Gene Symbol: ANGPTL4
Gene ID: 51129
Uniprot ID: ANGL4_HUMAN
Post Translational Modifications N-glycosylated. ANGPTL4 N-terminal chain: Forms disulfide-linked dimers and tetramers. Cleaved into a smaller N-terminal chain and a larger chain that contains the fibrinogen C-terminal domain.both cleaved and uncleaved forms are detected in the extracellular space. The cleaved form is not present within the cell.
Function Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity (Probable). Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stress fibers and focal adhesions in endothelial cells that have adhered to ANGPTL4-containing ECM (in vitro). Depending on context, may modulate tumor-related angiogenesis. ANGPTL4 N-terminal chain: Mediates inactivation of the lipoprotein lipase LPL, and thereby plays an important role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. Has higher activity in LPL inactivation than the uncleaved protein.
Protein Name Angiopoietin-Related Protein 4
Angiopoietin-Like Protein 4
Hepatic Fibrinogen/Angiopoietin-Related Protein
Hfarp Cleaved Into - Angptl4 N-Terminal Chain - Angptl4 C-Terminal Chain
Database Links Reactome: R-HSA-1989781
Reactome: R-HSA-381340
Reactome: R-HSA-8963889
Reactome: R-HSA-9762292
Cellular Localisation Secreted
Extracellular Space
Extracellular Matrix
The Unprocessed Form Interacts With The Extracellular Matrix
This May Constitute A Dynamic Reservoir
A Regulatory Mechanism Of The Bioavailability Of Angptl4 (Probable)
Alternative Nanobody Names Anti-Angiopoietin-Related Protein 4 nanobody
Anti-Angiopoietin-Like Protein 4 nanobody
Anti-Hepatic Fibrinogen/Angiopoietin-Related Protein nanobody
Anti-Hfarp Cleaved Into - Angptl4 N-Terminal Chain - Angptl4 C-Terminal Chain nanobody
Anti-ANGPTL4 nanobody
Anti-ARP4 nanobody
Anti-HFARP nanobody
Anti-PGAR nanobody
Anti-PP1158 nanobody
Anti-PSEC0166 nanobody
Anti-UNQ171 nanobody
Anti-PRO197 nanobody

Information sourced from Uniprot.org